Baldrige Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$375K Sell
1,550
-21
-1% -$5.16K 0.15% 79
2022
Q4
$413K Buy
1,571
+15
+1% +$4.02K 0.18% 73
2022
Q3
$351K Hold
1,556
0.17% 81
2022
Q2
$379K Hold
1,556
0.17% 79
2022
Q1
$376K Hold
1,556
0.15% 85
2021
Q4
$350K Hold
1,556
0.14% 84
2021
Q3
$331K Hold
1,556
0.14% 82
2021
Q2
$379K Hold
1,556
0.16% 78
2021
Q1
$387K Buy
1,556
+21
+1% +$5.01K 0.21% 65
2020
Q4
$353K Hold
1,535
0.21% 70
2020
Q3
$390K Hold
1,535
0.26% 60
2020
Q2
$362K Hold
1,535
0.27% 59
2020
Q1
$311K Hold
1,535
0.27% 61
2019
Q4
$370K Hold
1,535
0.31% 58
2019
Q3
$297K Hold
1,535
0.26% 60
2019
Q2
$283K Hold
1,535
0.26% 59
2019
Q1
$292K Buy
+1,535
New +$293K 0.29% 58

Other funds holding AMGN

Baldrige Asset Management's AMGN Position: Q1 2023 in Review

Baldrige Asset Management reduced its Amgen (AMGN) stake by 1.3% in Q1 2023, selling an estimated $5.16K and leaving 1,550 shares worth $375K. The position accounts for 0.15% of the portfolio, ranked #79.

Baldrige Asset Management first reported a position in AMGN in Q1 2019 and has held it in 17 quarters since. The position peaked at $413K in Q4 2022. 2,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.

  • Baldrige Asset Management held 1,550 shares of Amgen worth $375K as of Q1 2023.
  • Baldrige Asset Management sold 21 Amgen shares in Q1 2023, an estimated $5.16K.
  • Amgen made up 0.15% of Baldrige Asset Management's portfolio in Q1 2023, its #79 holding.
  • Baldrige Asset Management first reported a position in Amgen in Q1 2019 and has held it in 17 quarters since.
  • Baldrige Asset Management's Amgen position peaked at $413K in Q4 2022.
  • 2,434 funds tracked by Wall St. Rank held Amgen as of Q1 2023.

Based on Baldrige Asset Management's 13F filing for Q1 2023, filed 17 Apr 2023.